MSCL Satellos Bioscience Inc

0.56

0.00 (0.00%)

03 Jan 2025 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Satellos Bioscience Inc	TSXV:MSCL	TSX Venture	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	0.56	0.56	0.57				0	00:00:00

Satellos Bioscience Inc. Opens the Market

15/05/2024 4:04pm

PR Newswire (Canada)

Satellos Bioscience (TSXV:MSCL)
Historical Stock Chart

From Jan 2024 to Jan 2025

Click Here for more Satellos Bioscience Charts.

TORONTO, May 15, 2024 /CNW/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation to TSX.

Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. For more information, visit www.satellos.com.

CNW sponsored announcement. To learn more visit www.newswire.ca.

View original content to download multimedia:https://www.prnewswire.com/news-releases/satellos-bioscience-inc-opens-the-market-302146505.html